Aleksandr Shuster is a leading Russian drug development entrepreneur. He is a biochemist with special competences in Biotechnology, Molecular Biology, Molecular Immunology.

 

Aleksandr Shuster is co-owner of Trans Nova Investments Limited, which owns 40% of the shares in Affitech and IBC Generium, a Russian biotechnology company and partner of Affitech. He founded Lekko as the major shareholder of the company that developed a range of drugs which were bought by Pharmstandard. 

 

Aleksandr Shuster also founded the companies Masterpharm and Masterclone which primarily focus on new and biological drugs. Aleksandr Shuster is Chairman of the Board in Masterpharm, Lekko and MasterClone.